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Urinary tract obstruction is an important cause of acute renal failure. Several abnormalities in renal tubular function may occur in
obstructive nephropathy. The tubular secretion of organic anions is an important function of the kidney that eliminates potentially toxic
organic anions from the body, however, the mechanisms involved in organic anions renal elimination in rats with bilateral ureteral obstruction
(BUO) have not been elucidated. In this study, it was evaluated the renal handling of p-aminohippurate (PAH) in adult male Wistar rats with
BUO. A diminished renal clearance of PAH was observed in BUO rats as consequence of a diminution in the secreted load of this organic
anion. The increase in the abundance of organic anions transporter 1 (OAT1) and the absence of modification in cortical renal blood flow,
measured with fluorescence microspheres, do not explain the altered secretion of PAH. The diminished Na,K-ATPase activity in cortex from
obstructed kidneys might condition OAT1 function. Additionally, it is also possible to conclude that in the presence of BUO, PAH clearance
is not a good estimate of renal plasma flow.
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Ureteral obstruction is a common problem confronting
the urologist. Bilateral ureteral obstruction (BUO) is a
disorder, generally affecting males with urinary retention
due to hypertrophy of the prostate and in patients with
neurogenic bladder disorder. Although literature abounds in
animals and clinical research, the pathophysiologic mecha-
nisms accompanying ureteral obstruction have not been
fully elucidated. Nevertheless, it is well recognized that
obstructive nephropathy is not the result of a simple
mechanical impairment of urine flow but a complex syn-
drome resulting in both glomerular hemodynamics and
tubular functional alterations [1–5].
The tubular secretion of organic anions is an important
function of the kidney, eliminating potentially toxic organic
anions from the body [6]. Organic anions are taken up from
the peritubular plasma across the basolateral membrane and
effluxed into the tubular lumen through the luminal mem-0925-4439/$ - see front matter D 2004 Elsevier B.V. All rights reserved.
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the basolateral uptake, has been extensively characterized by
use of p-aminohippurate (PAH) as a prototypical substrate.
The organic anion transporter 1 (OAT1) is an organic anion/
dicarboxylate exchanger that has a wide substrate selectivity
for both endogenous and exogenous organic anions [7–12].
This is a tertiary active transport present in the basolateral
membranes of proximal tubules which is indirectly coupled
to the Na gradient established by Na,K-ATPase activity.
Several abnormalities in renal tubular function may occur
in obstructive nephropathy; nevertheless, the mechanisms
involved in organic anions renal elimination in rats with
BUO have not been elucidated. This study was undertaken
to characterize the mechanisms involved in PAH renal
elimination in rats with BUO.2. Materials and methods
2.1. Experimental animals
Male Wistar rats aged 110 to 130 days old were used
throughout the study (380 to 410 g in body weight).
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chow and tap water, and were housed in an environment of
constant temperature and humidity with regular light cycles
(12 h) during the experiments. The animals were cared for in
accordance with the principles and guidelines for the care
and use of laboratory animals. For surgical procedures the
animals were anaesthetized with sulfuric ether and ureters’
ligation and release were performed as previously described
[13]. The abdominal cavity was opened, and 2–0 silk
ligature was placed at both proximal ureters (t= 24 h).
After closure of the abdomen, the animals were kept for 24
h while they were given food and water ad libitum. The rats
were considered to have a successful ureteral obstruction
when ureteral diameter was >2 mm and hydronephrosis was
evident. The ureteral obstruction was released after 24
h (t = 0 h) and the rats, referred as bilateral obstruction
treated (BUO), were kept alive for 6 or 24 h thereafter (t = 6
h and t = 24 h). After this time, the rats were anaesthetized
with sodium thiopental (70 mg/kg b.wt., i.p) and all the
measurements were recorded. Corresponding control
groups, referred as Sham group, were treated the same,
except that no ureteral obstruction was performed. At
t = 24, 0, 6, and 24 h, blood samples were withdrawn
from the tail artery in order to measure the hematocrit and
urea plasma levels. The hematocrit was determined with a
Rolco CH24 centrifuge. Urea analyses were performed with
optimized spectrophotometric technique, employing a com-
mercial kit (Wiener Laboratory).
2.2. Renal function studies
2.2.1. Renal clearance studies
These studies were performed as previously described
[14,15]. At t = 24 h a group of BUO and Sham animals
were anaesthetized as described. Femoral vein and artery
were cannulated (P.E.50, Intramedic, USA) and a bladder
catheter (3-mm i.d.) was inserted through a suprapubic
incision. Animals were maintained in restraining cages
throughout the experiment to facilitate the collection of
urine. A priming dose of inulin (0.6 mg/kg b.wt.) and PAH
(30 mg/kg b.wt.) in 1 ml of saline solution was adminis-
tered through the venous catheter. Then, a solution con-
taining inulin (1.8 g%), PAH (0.6 g%) and saline solution
(0.3 g%) was infused through the venous catheter employ-
ing a constant infusion pump (Pump 22; Harvard Appara-
tus, USA) at a rate of 1 ml/h/100 g b.wt. After equilibrating
for 45 min, urine was collected during two 20-min periods.
Blood from the femoral artery was obtained at the midpoint
of each clearance period. Arterial blood pressure was
estimated throughout the experiments with a manometer
inserted in the femoral artery. The glomerular filtration rate
(GFR) was calculated from the clearance of inulin. Clear-
ance of PAH; excreted, secreted and filtered load of PAH;
the ratio of urine to plasma osmolality (U/P), the fractional
excretion of water (FE% H2O), sodium (FE% Na), potas-
sium (FE% K) and osmolytes (FE% Osm) were alsocalculated by conventional formulae for each animal.
PAH concentrations in serum and urine were determined
by the method of Waugh and Beall [16] and inulin
concentrations were determined by the procedure of Roe
[17]. Sodium and potassium were measured by flame
photometry and the volume of urine by gravimetry. Osmo-
lalities were determined in a freezing point osmometer
(Osmomat 030).
2.2.2. Renal blood flow determination
Another set of experimental animals at t = 24 h were used
to evaluate Cortical and Medullar Renal Blood Flow (cRBF,
mRBF) using fluorescent microspheres as described by
Glenny [18] and as previously applied in our laboratory
[15,19]. Orange microspheres (1106/kg b.w.) with a
diameter of 15 Am (Molecular Probes) were used. They
were infused in one shot into the carotid artery (previously
catheterized) followed by a washout with 1 ml of saline.
Arterial reference blood was collected from a catheter
inserted in the femoral artery at a rate of 1 ml/min, which
was started 15 s before injection and was continued for 60 s
after injection. Five minutes after the injection, the rats were
killed and the kidneys were rapidly removed and dissected
to obtain medulla and cortex. Blood samples were digested
overnight with 89.2% potassium hydroxide. The renal
cortex tissue was digested for 24 h with 22.4% potassium
hydroxide. Digested samples were filtered using Poretics
polycarbonate filters. The fluorescent dye was extracted
with 2-(2-ethoxyethoxy)ethyl acetate. After 1 h, the fluo-
rescence was measured at 540–560 nm. A known amount
of yellow-green microspheres (505–515 nm) was added to
each sample vial of blood and tissue prior to digestion.
These microspheres acted as internal standard. The RBF
was calculated by the formula: Renal Flow (ml/min) = fl/
flrefR (ml/min), where fl is the fluorescence of the renal
tissue, flref is the fluorescence of the reference blood
sample, and R is the withdrawal rate of the reference blood
sample.
2.3. Preparation of kidney cortex homogenates
Another group of BUO and Sham rats at t = 0, 6 and 24
h were anaesthetized as previously described and kidneys
were rapidly removed. The renal tissue was cleaned, dried,
weighed, and placed in saline. Then, renal cortex was
thoroughly homogenized in 250 mM sucrose, 10 mM
triethanolamine, 0.1 mg/ml phenylmethylsulfonyl fluoride
(PMSF). Protein quantification of samples was performed
using the method of Sedmak and Grossberg [20]. These
homogenates were used for measuring OAT1 abundance
and Na,K-ATPase activity.
2.3.1. Determination of OAT1 abundance by immunoblot
technique
Sham and BUO kidney cortex homogenate samples were
boiled for 3 min in the presence of 1% 2-mercaptoethanol/
Fig. 1. Urea plasma levels in Sham (n= 9) and BUO rats before (t= 24 h,
n= 6), after 24 h of ureter ligation (t = 0 h, n= 4) and after 6 and 24 h of ureter
release (t = 6 h, n= 4 and t = 24 h, n= 6). (a) P < 0.05 vs. Sham (t= 24 h),
(b) P< 0.05 vs. Sham (t = 0 h), (c) P < 0.05 vs. Sham (t = 6 h), (d) P < 0.05 vs.
Sham (t = 24 h).
Fig. 2. Renal clearance of PAH in Sham (n= 5) and BUO (t = 24 h, n= 5)
rats. The results are expressed as mean valuesF S.E. #P < 0.05.
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to a 8.5% gel, separated by SDS-PAGE, and then electro-
blotted to nitrocellulose membranes. For comparison be-
tween groups of animals, staining with ponceau red revealed
that equal quantities of proteins were deposited [21,22]. The
nitrocellulose membranes were then incubated overnight
with 5% nonfat dry milk in PBST. After being rinsed with
PBST, the membranes were incubated with a commercial
polyclonal antibody against OAT1 (1.25 Ag/ml) for 2 h.
Membranes were incubated for 1 h with a peroxidase
coupled goat antirabbit IgG (Bio-Rad) after further washing
with PBST. Blots were processed for detection using a
commercial kit (Opti-4CN amplified, Bio-Rad). To investi-
gate the specificity of the bands, an absorption test was
performed. The OAT1 peptide (1.25 Ag/ml) was added toTable 1
Body weight, kidneys weight, kidney/body weight ratio, mean arterial
blood pressure (MAP), glomerular filtration rate (GFR), urine to plasma
osmolality ratio (U/P) and fractional excretion of water (FE% H2O), sodium
(FE% Na), potassium (FE% K) and osmolytes (FE% Osm) in Sham and
BUO (t = 24 h) rats
Sham (n= 6) BUO (n= 5)
Body weight (g) 331F12 327F 10
Kidneys weight (g) 2.31F 0.09 3.22F 0.11*
Kidney/body weight ratio 0.00699F 0.00025 0.00986F 0.00027*
MAP (mm Hg) 115F 2 130F 7
GFR (ml/min/kg b.wt.) 0.582F 0.053 0.127F 0.020*
FE% H2O 0.876F 0.090 9.86F 1.57*
FE% Na 1.28F 0.19 50.32F 11.65*
FE% K 31.99F 4.51 87.62F 5.54*
FE% Osm 3.00F 0.15 15.14F 2.01*
U/P 3.71F 0.44 1.56F 0.06*
Results are expressed as mean valuesF S.E.
* P< 0.05.the OAT1 antibody specific solution (1.25 Ag/ml) and
incubated for 2 h. Using this preabsorbed antibody, Western
blot analysis was performed as described above. A densito-
metric quantification of Western blot signal intensity of
membranes was performed.
2.3.2. Na,K-ATPase activity assay
Na,K-ATPase activity was estimated as the difference
between the amounts of inorganic phosphate liberated in the
absence (total ATPase) and in the presence (Mg2 +-ATPase)
of ouabain [23]. The release of inorganic phosphate was
measured according to Widnell [24].
2.4. Materials
Chemicals were purchased from Sigma Chemical (St.
Louis, MO, USA) and were analytical grade pure. Poly-
clonal antibodies against OAT1 and the OAT1 peptide were
purchased from Alpha Diagnostic International (San Anto-
nio, TX, USA).
2.5. Statistical analysis
Statistical analyses were performed using an unpaired t-
test. When variances were not homogeneous, a Welch
correction was employed. P values less than 0.05 were
considered significant. Whenever more than two means
were to be compared, analysis of variance was used. When
F value was significant (P < 0.05), the group means wereTable 2
Excreted, filtered and secreted load of PAH in Sham and BUO (t = 24 h) rats
Sham (n= 6) BUO (n= 5)
Excreted load of PAH (Ag/min/100 g b.wt.) 176.9F 10.6 92.3F 12.5*
Filtered load of PAH (Ag/min/100 g b.wt.) 20.24F 1.89 27.99F 2.83
Secreted load of PAH (Ag/min/100 g b.wt.) 156.7F 10.2 64.3F 13.2*
Results are expressed as meansF S.E.
* P < 0.05.
Fig. 3. Cortical renal blood flow in Sham (n= 4) and BUO (t= 24 h, n= 4)
rats. The results are expressed as mean valuesF S.E. #P< 0.05.
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ences. Values are expressed as meanF S.E. For these
analyses GraphPad software was used.3. Results
Fig. 1 shows a statistically significant increase in urea
plasma levels after 24 h of ureteral obstruction (t= 0 h)
which persisted to be elevated 24 h after its release (t = 24 h)
as compared with corresponding Sham operated animals.
No statistically significant differences between groups were
observed in hematocrit determinations.Fig. 4. Time courses of changes in OAT1 abundance and Na,K-ATPase activity in k
BUO (t = 0 h, n= 4; t = 6 h, n= 4; t = 24 h, n= 6). (A) Western blot analysis of OAT
Materials and methods. (B) Densitometric quantification of OAT1 (Sham levels we
valuesF S.E. (a) P< 0.05 vs. Sham; (b) P < 0.05 vs. BUO, t = 0 h.Renal function studies were performed at 24 h after
release of BUO. Body weight, kidney weight, kidney/body
weight ratio, mean arterial pressure, GFR, FE%Na, FE%K,
FE%H2O, FE%Osm, and U/P are summarized in Table 1.
Kidney weight, kidney/body weight ratio and fractional
excretions of Na, K, H2O and osmolytes were significantly
higher in BUO than in Sham rats. GFR and U/P were
decreased in BUO rats. As shown in Fig. 2, the renal
clearance of PAH was significantly lower in BUO rats.
Table 2 shows the filtered, secreted and excreted loads of
PAH. No statistically significant difference was observed in
the filtered load. On the contrary, the excreted load of PAH
was significantly lower in BUO rats as a consequence of a
reduction of secreted load. Cortical RBF obtained with the
fluorescence microspheres technique was not statistically
different between groups (Fig. 3). On the contrary, the
filtration fraction (FF) was decreased at 24 h after release
of BUO (S = 0.15F 0.01, n = 4 vs. BUO = 0.04F 0.01,
n = 4; P < 0.05). No differences between groups were ob-
served in medullar RBF (S = 0.180F 0.031, n = 4 vs.
BUO= 0.184F 0.057, n = 4; ml/min/100 g b.wt.).
Fig. 4 illustrates time courses of changes in Na,K-ATPase
activity and in OAT1 protein abundance in homogenates
from kidney cortex of Sham and BUO rats. Sham operated
rats showed no differences in both parameters when studied
at different times postsurgery. Thus, the values were aver-
aged and presented as only one group. Na,K-ATPase activ-
ity decreased significantly in homogenates from kidney
cortex of BUO rats at t = 6 h and t= 24 h as compared with
Sham rats. On the contrary, OAT1 abundance increasedidney cortex homogenates from Sham (n= 13) and BUO rats after release of
1 protein. OAT1 was identified using polyclonal antibodies as described in
re set at 100%) and Na,K-ATPase activity. The results are expressed as mean
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bands were ablated by used of antibody previously absorbed
with immunizing peptide (data not shown).4. Discussion
Urinary tract obstruction is an important cause of acute
renal failure (ARF). ARF is characterized by the rapid
(hours to weeks) decline of the GFR and the retention of
nitrogenous waste products such as blood urea nitrogen and
creatinine. The measure of these products is likely to remain
as the principal method of ARF diagnosis [25–27].
We observed a consistent increase in urea plasma levels
after 24 h of ureteral obstruction (t = 0 h), which remained
elevated after 24 h of ureteral release which indicates the
presence of ARF in our experimental model.
Following ureteral obstruction, the kidneys of BUO
groups consistently increased in weight, which is presum-
ably due to the accumulation of edema in the early phase of
obstruction. GFR decreased without modification in the
renal blood flow (both cortical and medullar). This leads
to a decreased filtration fraction in the postobstructed
kidney. This may reflect preferential constriction of the
preglomerular blood vessels. Alternatively, it suggests that
there is either diversion of blood to nonfiltering areas of the
kidney or that there is a reduced area available for filtration
per glomerulus, this previously suggested by Ichikawa et al.
[28], where Kf values from rats with ureteral obstruction
were lower than those typically obtained in normal rats.
The release of BUO results in a dramatic increase in
sodium, potassium and water excretion in the urine. In this
sense, it has been described that there is a decrease in
sodium reabsorption in both the proximal and the distal
tubule after BUO [4]. The increase in potassium secretion
may be the result of an increase in water and sodium
delivery to the distal nephron. BUO rats also presented an
increase in FE% Osm and a decrease in U/P ratio. In this
connection, several factors appear to be involved in the
reduced concentrating ability observed of the post-release
kidney such as the reduced capacity of the thick ascending
limb of Henle’s loop to reabsorb NaCl [29], which results in
a decrease in medullary solute concentration, the unrespon-
siveness to vasopressin of collecting duct [29] and the
down-regulation of AQP-2 water channel [30].
The mammalian renal proximal tubule plays an important
function by rapidly clearing the blood of many drugs. In this
regard, the organic anion secretory pathway of the kidney
has evolved to mediate the excretion of a wide array of
negatively charged organic compounds, and PAH has be-
come the model substrate used to functionally characterize
the luminal and basolateral membrane transport mecha-
nisms. A variety of xenobiotics, toxins, endogenous com-
pounds and their metabolites are classified as organic
anions, many of which are eliminated via this carrier-
mediated pathway(s) at the proximal tubules. A number ofdrugs, such as h-lactam antibiotics, diuretics, nonsteroidal
anti-inflammatory drugs, and several antiviral drugs, are
also classified as organic anions; therefore, the renal organic
anion transport pathway plays a key role in the pharmaco-
kinetics of these drugs [8,9]. The systems involved in
organic anion secretion can be functionally subdivided in
the well-characterized sodium-dependent PAH system and a
recently discovered sodium-independent system. Both sys-
tems mediate two membrane translocation steps arranged in
series: uptake from blood across the basolateral membrane
of renal epithelial cells followed by efflux into urine across
the apical membrane. A lot of organic anions transporters
have been recently cloned. Various groups have cloned the
OAT1, which represents the classical basolateral PAH/
dicarboxylate exchanger [11,12]. In the apical membrane,
multidrug resistance protein 2 (MRP2) has been described
as one of PAH transporters [7,10]. Organic anion trans-
porters k1 and k2 (OAT-K1 and OAT-K2) are present in
luminal membrane of proximal tubule, but they do not
transport PAH [9].
The goal of this study was to evaluate for the first time
the organic anion renal handling in obstructive nephropathy
using PAH as prototypical drug.
It is well known that impairment of the kidney function
produces modifications in the renal elimination of drugs
mediated by alterations in blood flow to the kidney, glo-
merular filtration, active tubular secretion, and passive
tubular reabsorption.
In rats with BUO, the renal clearance of PAH decreased
as consequence of the diminution in the secreted load of the
organic anion. Between the determinants of tubular secre-
tion of organic anions, it is possible to mention RBF and the
organic anions transport system. As we did not observe
modification in RBF, we decided to evaluate the abundance
of OAT1. OAT1 plays a primary role in the tubular secretion
of endogenous and exogenous organic anions. An unex-
plored aspect of OAT1 regulation concerns the body’s
response to disease state. An increase in the abundance of
OAT1 was observed in rats with BUO after 6 and 24 h of
ureteral obstruction release. In this regards, it has been
described that ureteral obstruction also produces changes
in gene transcription [4]. In light of these results, we
postulated that the increase in the abundance of OAT1
might be produced in the absence of good conditions for
its functionality. As the transport of organic anions by OAT1
occurs by indirect coupling of the sodium gradient, and this
gradient is generated by Na,K-ATPase pump, we evaluated
its activity in homogenates from kidney cortex. The dimin-
ished activity of Na,K-ATPase, in addition to the decreased
cellular ATP content described in obstructed kidney [31],
may explain the unfunction of OAT1 as a consequence of
the impairment in the sodium gradient. A decrease in
cortical Na,K-ATPase activity has been recently described
in rabbit kidneys after BUO [32]. The results that we
observed in the time courses of changes in OAT1 abundance
and Na,K-ATPase activity suggest that some relationship
S.R. Villar et al. / Biochimica et Biophysica Acta 1688 (2004) 204–209 209between the behavior of both parameters may exist, which
merits further studies.
The other goal of this study was that in the presence of
BUO, PAH clearance is not a good estimate of renal plasma
flow. Renal plasma flow usually is measured using PAH
clearance techniques. During a single pass, 85–90% of the
PAH may be extracted from the blood. As BUO induces a
diminished tubular secretion of PAH, this results in a
diminished elimination of this compound from the organism
as demonstrated by the diminished PAH clearance. In this
case, PAH clearance cannot be used as an estimate of renal
blood flow, which is evidenced by the absence of modifi-
cation of renal cortical blood flow demonstrated by the
measurement of this parameter employing fluorescence
microspheres.Acknowledgements
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